Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox’s NCX 470 Mont Blanc Phase 3 Glaucoma Trial Reaches 50% Enrollment Milestone

March 23, 2021

View Press Release Corporate presentation Contact us
Previous